Evaluating only Hysata’s profile at its peak — without knowing the outcome — the model ranked Regulation as the #1 likely cause. Documented cause: Market collapse.
Key Events Timeline
FOUNDING
Paul Barrett and Gerry Swiegers spin out Hysata from University of Wollongong with CSIRO backing.
FUNDING
Raises AUD $42M Series A; publishes Nature Communications paper claiming 95% electrolysis efficiency record.
PRODUCT LAUNCH
Begins pilot electrolyzer stack manufacturing; Australian H2 projects face 40% cost overruns industrywide.
SHUTDOWN
Wind-down announced after Series B fundraise fails; no commercial electrolyzer customers secured.
Full Analysis
Free · no account needed
Documented cause
Hysata raised AUD $42M from CSIRO, IP Group and others claiming its capillary-fed electrolyzer achieved 95% efficiency — potentially the world's most efficient electrolysis device. However, by 2024, the company could not secure follow-on funding as Australia's National Hydrogen Strategy lost momentum, global hydrogen project cancellations accelerated, and investors demanded commercial demonstration the company could not yet provide, forcing a wind-down of operations.
Lesson
“Efficiency breakthroughs mean nothing without a commercial hydrogen market willing to pay for them at scale.”